Glaukos Featured in Numerous Scientific Abstracts at the 2023 ASCRS Meeting

Glaukos announced that its technologies will be featured in various scientific programming at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, being held May 5–8, 2023 in San Diego. Glaukos will be exhibiting onsite at booth #1237.

Key Glaucoma Presentations:

Saturday, May 6, 2023

• 1:30 – 1:35 p.m., Gerd U. Auffarth, MD, PhD
  Sustained 7-Year Glaucoma Control after Second-Generation Trabecular Micro-Bypass with or without Cataract Surgery
• 2:06 – 2:11 p.m., Ike K. Ahmed, MD
  Prospective Study of Standalone Multiple Trabecular Micro-Bypass Stents for Uncontrolled Glaucoma
• 2:16 – 2:21 p.m., John P. Berdahl, MD
  Outcomes of the Prospective Randomized Controlled Multicenter Phase III Trials of iDose® TR Versus Topical Timolol
• 2:21 – 2:26 p.m., Mitchell C. Shultz, MD
  Stratified Outcomes of 2 Different Trabecular MIGS Devices with or without Ab-Interno Canaloplasty in Mild and Moderate Open-Angle Glaucoma
• 2:52 – 2:57 p.m., Ticiana De Francesco, MD
  Long-Term Endothelial Safety with 2nd-Generation Trabecular Micro-Bypass in Patients with Open-Angle Glaucoma

Key Glaucoma Posters:

• Tanner J. Ferguson, MD
  iStent inject Trabecular Micro-Bypass Stent Implantation with Cataract Extraction in Open-Angle Glaucoma: Long-Term Results
• Mark J. Gallardo, MD
  Trabecular Micro-Bypass +/- Precision Blade Goniotomy to Potentiate Aqueous Outflow & Reduce Intraocular Pressure in Glaucoma
• Ae Ra Kee, MBBS, FRCOphth
  Combined Phacoemulsification and iStent inject versus Combined Phacoemulsification and Hydrus® Microstent in South East Asian Eyes
• Xiongfei Liu, MD
  Effectiveness and Safety of Combining Two MIGS Devices in Patients with Open-Angle Glaucoma
• Mitchell C. Shultz, MD
  Effectiveness and Safety of 2 Different Trabecular MIGS Devices in Patients with Mild-to-Moderate Glaucoma

Key Corneal Health Presentations:

Saturday, May 6, 2023

• 1:30 – 1:35 p.m., Miguel Rechichi, PhD, MD
  Eight Year Results of Accelerated Epi-off Corneal Cross-Linking in Patients with Progressive Keratoconus

Sunday, May 7, 2023

• 1:40 – 1:45 pm, Steven Greenstein, MD
  10-Year Follow-up for Collagen Cross-Linking in Keratoconus and Ectasia: Comparison of Outcomes with Subsequent Topography-Altering Surgery
• 1:45 – 1:50 p.m., Julia Yu, BSc
  Dynamics of Corneal Swelling during Corneal Collagen Cross-Linking in Progressive Keratoconus Patients
• 1:51 – 1:56 p.m., Miltos Balidis, PhD, MD
  Customized Transepithelial Cross-Linking for Keratoconus: 2-Year Follow-up
• 2:11 – 2:16 p.m., Philip Dockery, MD
  Corneal Cross-Linking for Patients with Progressive Keratoconus and Thin Corneas
• 3:47 – 3:55 p.m., Kenneth A. Beckman, MD
  Update on Cross-Linking: Epi-on FDA Trial and Beyond

Key Corneal Health Posters:

• Brendan G. Cronin, FRANZCO, MBBS
  Oxygen-Supplemented and Topography-Guided Epi-on Corneal Cross-Linking with Pulsed Irradiation for Progressive Keratoconus

Key Corneal Health Course:

Saturday, May 6, 2023

• 8:00 – 9:30 a.m., Miguel Rechichi, PhD, MD
  Keratoconus State of the Art: New Cutting-Edge Treatments for Corneal Ectasia (IC-105)
  Co-instructors: Ashraf Armia Balamoun, MD, Miltiadis Balidis, PhD, MD, William B. Trattler, MD

Abstract information can be found at www.ascrs.org.